Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 91 for “"Bupropion"”.
-
Characterizing bupropion metabolism, pharmacokinetics and drug-drug interaction liability
Bupropion is a norepinephrine and dopamine reuptake inhibitor that is currently indicated for use as an antidepressant (Wellbutrin), a smoking cessation aid (Zyban) and a weight loss therapy in combination with naltrexone (Contrave). Bupropion is also the preferred sensitive in vivo CYP2B6 …
-
Pharmacokinetics of Bupropion and its Pharmacologically Active Metabolites in Pregnancy
Bupropion, an antidepressant and anti-smoking medication, is used for treatment of depression during pregnancy, however its efficacy as a smoking cessation aid in pregnancy has not been confirmed. The drug is extensively biotransformed by liver with the formation of pharmacologically active …
-
EFFECTS OF BUPROPION DURING SMOKING ABSTINENCE ON LORETA-ASSESSED FRONTAL LOBE ACTIVITY
Bupropion, an atypical antidepressant medication, is a well-documented efficacious smoking cessation aide, but little is known about the brain areas that are affected when smokers quit with and without use of bupropion. Findings indicate that nicotine withdrawal is associated with reductions in …
-
Long-Term Impacts of Bupropion Exposure during Critical Developmental Periods on Reward Learning
… producing maladaptive behavioural output. Bupropion (BUP) is a norepinephrine and dopamine reuptake inhibitor prescribed off-label for juvenile ADHD. Short- and long-term effects of BUP during critical periods of postnatal development were evaluated to assess reward-related neurobehavioural …
-
Impulsivity As A Predictor Of Smoking Cessation Outcomes In Bupropion Treatment Of Community Corrections Smokers
… enrolled in a randomized control trial that used bupropion to treat tobacco dependence. This study found that inattention was a significant barrier to treatment. Specifically, performance on measures of attention including number of omissions errors on the Conner's Continuous Performance Task - …
-
Structure-Activity Relationship Studies of Bupropion and Related 3-Substituted Methcathinone Analogues at Monoamine Transporters
… of neurotransmitters from the synaptic cleft. Bupropion (DAT/NET reuptake inhibitor) is clinically prescribed for the treatment of depression and smoking cessation, whereas its closely related cousin, cathinone (DAT/NET releasing agent), is a drug of abuse. Deconstruction of bupropion (i.e., a …
-
Manipulating dopaminergic activity with bupropion: effects on reward and emotional processing biases implicated in depression
… affecting dopaminergic activity, such as bupropion. The current thesis aimed to delineate the role of the dopaminergic reward system in the cognitive neurobiological processes underlying the two symptom clusters of low mood and anhedonia in major depressive disorder. In order to do this, …
-
Preparation and Activity of Multidentate beta-Amino Sulfoxide Ligands and Expedited Catalytic Preparation of Bupropion
… anions. Expedited catalytic preparation of Bupropion: α-Amino carbonyl compounds represent a diverse group of synthetically valuable compounds ranging from synthetically valuable compounds, ranging from synthetic building blocks to biologically significant natural products. Moreover, the …
-
A Study of the Inhibitory and Pharmacological Chaperone Effects of Bupropion and Ibogaine on Monoamine Transporters
… the action of two atypical DAT inhibitors: bupropion and ibogaine. These drugs are classified as atypical inhibitors due to their binding pose and non-reinforcing effects. Research has supported that ibogaine also inhibits 5-HT uptake via SERT, but bupropion does not. In several studies, …
-
THE EFFECTIVENESS OF BUPROPION SR ON DEPRESSIVE SYMPTOMS IN SMOKERS: SELF-REPORTS, EEG, AND INDIVIDUAL DIFFERENCES
… depressed, were randomly assigned to the Bupropion group (n = 30) or Placebo group (n = 80) in this double blind study. EEG data during the performance of a visuospatial task were collected prior to and after 14 days on bupropion or placebo capsules. It was found that bupropion …
-
Stereoselective disposition of bupropion and its three major metabolites : 4-hydroxybupropion, erythro-dihydrobupropion, and threo-dihydrobupropion
Bupropion is a dual dopamine-norepinephrine uptake inhibitor and a nicotine receptor antagonist. Clinically, bupropion is given as a racemate for the management of depression, smoking cessation aid, and for the management of weight. Bupropion has also been targeted as a phenotypic probe of CYP2B6 …
-
Die Bedeutung genetischer Polymorphismen im Enzym Cytochrom P450 2B6 für Pharmakokinetik und Wirkung des Antidepressivums Bupropion
Bupropion wird in der medikamentösen Therapie von Depressionen sowie zur Nikotinentwöhnung angewendet. Genetische Polymorphismen können verantwortlich sein für Nebenwirkungen wie Krampfanfälle. Bupropion wird metabolisiert durch das Cytochrom P450 2B6 (CYP2B6). Wir untersuchten die Auswirkungen …
-
Serotonin Syndrome and/or Opioid Withdrawal after the First Dose of Naltrexone HCl/Bupropion HCl: an Observational Study
… and Drug Administration approved naltrexone HCl/bupropion HCl, a combination of an antidepressant and an opioid antagonist for chronic weight management therapy. Concurrent use of antidepressants and opioids has the potential to cause drug interactions involving serotonin syndrome. Our primary …
-
SHORT AND LONG-TERM EFFECTS OF TOBACCO ABSTINENCE, BUPROPION AND NICOTINE ON BRAIN ACTIVITY DURING A VISUOSPATIAL TASK
… is the cognitive deficits caused by abstinence. Bupropion (BUP) and nicotine replacement therapy (NRT) are two of the three FDA-approved efficacious pharmacotherapies to assist in nicotine abstinence. Very little is known about the differences between the neurocognitive effects of NRT and BUP. …
-
A quantitative analysis of the value-enhancing effects of nicotine, bupropion, and varenicline in male and female rats
… most commonly prescribed smoking cessation aids, bupropion and varenicline. The present dissertation investigated the value-enhancing effects of nicotine, bupropion and varenicline in both male and female rats using a behavioral economic, reinforcer demand approach. Additionally, the role of …
-
An fMRI study on the effects of the dopamine & noradrenaline reuptake inhibitor bupropion on reward processing in depressed individuals
… This thesis investigates the effects that bupropion, a dual reuptake inhibitor of dopamine and noradrenaline, has on the neural substrates implicated in reward processing amongst clinically depressed individuals compared to unmedicated healthy controls. This investigation may help elucidate …
-
Der Einfluss der Substanzen Aswal und Bupropion auf die synaptische Übertragung in der CA1-Region hippocampaler Gewebsschnitte von Meerschweinchen
… wurde das atypische Antidepressivum Bupropion elektrophysiologisch untersucht sowie sein Einfluß auf die LTP. Bupropion zeigte passend zur postulierten dopaminergen Wirkweise excitatorische Eigenschaften und führte zu einer signifikanten Inhibition der LTP, welche gut mit der Blockade …
-
In vivo neurochemical effects of antidepressant treatments studied by microdialysis
… (DMI), b) the novel antidepressant drug bupropion, and c) electrically induced seizures (ECS). The following results were obtained: 1) Neither acute (5 mg/kg), nor chronic (5 mg/kg, b.i.d. X 21) DMI influenced basal interstitial concentrations of DA in the NAC or the striatum. Chronic DMI …
-
Impact of Medications Used in the Treatment of Mood Disorders on Monoaminergic Systems
… techniques, the effects of co-administration of bupropion with the SSRI escitalopram on the firing rate of dorsal raphe 5-HT and locus coeruleus norepinephrine (NE) neurons were investigated. Escitalopram significantly decreased the firing of 5-HT and NE neurons at day 2. The 5-HT firing rate, …
-
Acute pharmaceutical poisoning as a cause of seizure events: a database analysis (2011–2023)
… Mefenamic acid (15.7%), quetiapine (10%), and bupropion (10%) were most commonly associated with seizures. Cefepime (37.5%) and bupropion (23.7%) showed the highest seizure potentials. Seizures occurred at low relative overdoses for clozapine, chlorprothixene, and trimipramine (1.3×, 2.0×, …
Page 1 of 5